Gilead Sciences, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Gilead Sciences, Inc. now
Current reporting with the operating signal separated from the noise.
Gilead Sciences, Inc (GILD) Stock Price & News - Google Finance
Investors are testing whether Gilead Sciences, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Is Most-Watched Stock Gilead Sciences, Inc. (GILD) Worth Betting on Now?
Investors are testing whether Gilead Sciences, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Gilead Sciences, Inc. Revenue Breakdown – BIVA:GILD
Investors are testing whether Gilead Sciences, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Gilead Sciences, Inc. (GILD) BofA Securities Health Care Conference Transcript
The story matters when it changes Gilead Sciences, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest GILD filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Gilead Sciences, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →